Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Generation of human antibodies targeting human platelet antigen (HPA)-1a.
Oosterhoff JJ, Linty F, Visser R, de Vos T, Hofstede-van Egmond S, van de Weerd M, Porcelijn L, de Haas M, van der Schoot E, Vidarsson G. Oosterhoff JJ, et al. Among authors: de haas m. Transfusion. 2024 May;64(5):893-905. doi: 10.1111/trf.17758. Epub 2024 Feb 24. Transfusion. 2024. PMID: 38400657
Transcriptional and functional profiling identifies inflammation and endothelial-to-mesenchymal transition as potential drivers for phenotypic heterogeneity within a cohort of endothelial colony forming cells.
Laan SNJ, de Boer S, Dirven RJ, van Moort I, Kuipers TB, Mei H, Bierings R, Eikenboom J; SYMPHONY consortium. Laan SNJ, et al. J Thromb Haemost. 2024 Apr 2:S1538-7836(24)00176-4. doi: 10.1016/j.jtha.2024.03.018. Online ahead of print. J Thromb Haemost. 2024. PMID: 38574861 Free article.
Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease.
Jalink JM, Jacobs CFJ Dr, Khwaja JK, Evers DE, Bruggeman CB, Fattizzo BF, Michel MM, Crickx EC, Hill QAH, Jaeger UJ, Kater APK, Mäkelburg ABUM, Breedijk AB, Te Boekhorst PAW, Hoeks MPAH, de Haas MdH, D'Sa SPD, Vos JMI. Jalink JM, et al. Among authors: de haas mdh. Blood Adv. 2024 Mar 20:bloodadvances.2024012585. doi: 10.1182/bloodadvances.2024012585. Online ahead of print. Blood Adv. 2024. PMID: 38507742
Extensive red blood cell matching considering patient alloimmunization risk.
Wemelsfelder ML, van de Weem RHG, Luken JS, de Haas M, Niessen RWLM, van der Schoot CE, Hoogeveen H, Oyebolu FB, den Hertog D, Janssen MP. Wemelsfelder ML, et al. Among authors: de haas m. Vox Sang. 2024 Apr;119(4):368-376. doi: 10.1111/vox.13594. Epub 2024 Jan 29. Vox Sang. 2024. PMID: 38286764
Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.
Ree IMC, de Haas M, van Geloven N, Juul SE, de Winter D, Verweij EJT, Oepkes D, van der Bom JG, Lopriore E. Ree IMC, et al. Among authors: de haas m. Lancet Haematol. 2023 Dec;10(12):e976-e984. doi: 10.1016/S2352-3026(23)00285-5. Lancet Haematol. 2023. PMID: 38030319 Clinical Trial.
336 results